Gegen-Sangshen oral liquid and its active fractions mitigate alcoholic liver disease in mice through repairing intestinal epithelial injury and regulating gut microbiota
Shulin Wei(Southwest Medical University), Xu Wu(Southwest Medical University), Yubin Liu(Shenzhen Bay Laboratory), Long Zhao(Huazhong University of Science and Technology), Yueshui Zhao(Southwest Medical University), Fukuan Du(Southwest Medical University), Jiayue Yang(Southwest Medical University), Tiangang Wang(Southwest Medical University), Wei Mei(Southwest Medical University), Zhangang Xiao(Southwest Medical University), Xiaobing Li(Jinan University), Yu Chen, Mingxing Li(Southwest Medical University), Yuhong Sun(Southwest Medical University), Zhi Li(Southwest Medical University), Jing Shen(Peking University), Ke Wu(Southwest Medical University), Wanping Li(Southwest Medical University), Gu Li(Southwest Medical University), Shuai Deng(Southwest Medical University)
Cited by 6
Related Papers
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
|International Journal of Biological Sciences|2022|226
NAFLD and NASH: etiology, targets and emerging therapies
|Drug Discovery Today|2024|181